393641592	393641592	CD	B-NP	O
|	|	NN	I-NP	O
IOEH	IOEH	NN	I-NP	O
|	|	NN	I-NP	O
96545815	96545815	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
509676	509676	CD	B-NP	O
|	|	CC	I-NP	O
2/1/1996	2/1/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/1/1996	2/1/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/21/1996	11/21/1996	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
OPTIC	OPTIC	NN	B-NP	O
NEURITIS	NEURITIS	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
SIGNIFICANT	SIGNIFICANT	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
DDD	DDD	NN	B-NP	B-protein
pacer	pacer	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Sleep	Sleep	JJ	B-NP	B-protein
apnea	apnea	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Asthma	Asthma	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Anemia	Anemia	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
54	54	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
lady	lady	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
DDD	DDD	NN	I-NP	B-DNA
pacer	pacer	NN	I-NP	I-DNA
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
gradual	gradual	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
headache	headache	NN	I-NP	O
and	and	CC	O	O
slowly	slowly	RB	B-NP	O
progressive	progressive	JJ	I-NP	O
visual	visual	JJ	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
flu	flu	NN	I-NP	O
vaccination	vaccination	NN	I-NP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
TLETQUEEN	TLETQUEEN	NNP	B-NP	O
FORDBREWAL	FORDBREWAL	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
AND	AND	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
above	above	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
visual	visual	JJ	I-NP	O
acuity	acuity	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
decline	decline	VB	I-VP	O
to	to	TO	I-VP	O
frank	frank	VB	I-VP	O
blindness	blindness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ophthalmology	ophthalmology	NN	I-NP	O
appointment	appointment	NN	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
bilateral	bilateral	JJ	B-NP	O
papilledema	papilledema	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
hemorrhages	hemorrhage	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
referred	refer	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
for	for	IN	B-PP	O
lumbar	lumbar	JJ	B-NP	O
puncture	puncture	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
with	with	IN	B-PP	O
contrast	contrast	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
lumbar	lumbar	NN	I-NP	O
puncture	puncture	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
opening	opening	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
290	290	CD	B-NP	O
and	and	CC	O	O
elevated	elevate	VBN	B-VP	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
160	160	CD	B-NP	O
,	,	,	O	O
primarily	primarily	RB	B-NP	O
lymphocytosis	lymphocytosis	NN	I-NP	O
of	of	IN	B-PP	O
83	83	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
93	93	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
pseudotumor	pseudotumor	NN	I-NP	O
cerebri	cerebri	NN	I-NP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	I-NP	O
Diamox	Diamox	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Ophthalmology	Ophthalmology	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
leading	lead	VBG	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
was	be	VBD	B-VP	O
pseudotumor	pseudotumor	NN	B-NP	O
cerebri	cerebri	NN	I-NP	O
versus	versus	IN	B-PP	O
optic	optic	JJ	B-NP	O
neuritis	neuritis	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
DDD	DDD	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Nifedipine	Nifedipine	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
alternating	alternate	VBG	B-VP	O
at	at	IN	B-PP	O
7.5	7.5	CD	B-NP	O
and	and	CC	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
p.r.n.	p.r.n.	NN	B-NP	O
Motrin	Motrin	NNP	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
known	know	VBN	B-VP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	O
technician	technician	NN	I-NP	O
who	who	WP	B-NP	O
works	work	VBZ	B-VP	O
at	at	IN	B-PP	O
Cal	Cal	NNP	B-NP	O
Pe	Pe	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
She	She	NNP	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cigarette	cigarette	NN	B-NP	O
smoking	smoking	NN	I-NP	O
since	since	IN	B-PP	O
1978	1978	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
separated	separate	VBN	I-VP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
five	five	CD	B-NP	O
daughters	daughter	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
son	son	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
lung	lung	NN	B-NP	O
,	,	,	O	O
thyroid	thyroid	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
questionable	questionable	JJ	B-NP	O
head	head	NN	I-NP	O
and	and	CC	O	O
neck	neck	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
or	or	CC	I-NP	O
brain	brain	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
68	68	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/88	150/88	CD	I-NP	O
,	,	,	O	O
afebrile	afebrile	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
mildly	mildly	RB	B-NP	O
proptotic	proptotic	JJ	I-NP	O
eyes	eye	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ocular	ocular	JJ	B-NP	O
pulsations	pulsation	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sinus	sinus	NN	I-NP	O
or	or	CC	I-NP	O
scalp	scalp	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
,	,	,	O	O
nontender	nontender	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
lymphadenopathy	lymphadenopathy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
essentially	essentially	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	B-protein
exam	exam	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
being	be	VBG	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	B-protein
x	x	NN	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cranial	cranial	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
papilledema	papilledema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EVALUATION	EVALUATION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
BUN/creatinine	BUN/creatinine	NN	B-NP	O
of	of	IN	B-PP	O
11/0	11/0	CD	B-NP	O
.9	.9	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
9.6	9.6	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
36	36	CD	I-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
serologies	serology	NNS	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

RPR	RPR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Serologic	Serologic	JJ	B-NP	O
tests	test	NNS	I-NP	O
for	for	IN	B-PP	O
ANA	ANA	NN	B-NP	O
are	be	VBP	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Glucose	Glucose	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CSF	CSF	NN	I-NP	B-protein
was	be	VBD	B-VP	O
65	65	CD	B-NP	O
.	.	.	O	O

Gram	Gram	NN	B-NP	B-protein
stain	stain	NN	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CSF	CSF	NN	I-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
CSF	CSF	NN	I-NP	B-protein
were	be	VBD	B-VP	O
subsequently	subsequently	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

Lyme	Lyme	NN	B-NP	O
test	test	NN	I-NP	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
however	however	RB	B-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Neurology	Neurology	NNP	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
IV	IV	CD	B-NP	O
q.day	q.day	NN	I-NP	O
x	x	SYM	B-NP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Diamox	Diamox	NN	B-NP	O
500	500	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
here	here	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
uneventful	uneventful	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
partial	partial	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
vision	vision	NN	I-NP	O
to	to	TO	B-PP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
see	see	VB	I-VP	O
shadows	shadow	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
headache	headache	NN	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
systemic	systemic	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
admitting	admit	VBG	I-NP	O
medications	medication	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
q.day	q.day	NN	I-NP	O
IV	IV	CD	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
beginning	begin	VBG	B-VP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
by	by	IN	B-PP	O
20	20	CD	B-NP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
alternating	alternate	VBG	B-VP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
Saturday	Saturday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
and	and	CC	O	O
Tuesday	Tuesday	NNP	B-NP	O
and	and	CC	O	O
7.5	7.5	CD	B-NP	O
on	on	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
,	,	,	O	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

Axid	Axid	NN	B-NP	O
150	150	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
CONDITION	CONDITION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Good	Good	NNP	B-NP	O
,	,	,	O	O
apart	apart	RB	B-ADVP	O
from	from	IN	B-PP	O
partial	partial	JJ	B-NP	O
blindness	blindness	NN	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
followup	followup	NN	B-NP	O
in	in	IN	B-PP	O
Ophthalmology	Ophthalmology	NN	B-NP	O
clinic	clinic	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bathke	Bathke	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
neurology	neurology	NN	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tiffner	Tiffner	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
1996	1996	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
VNA	VNA	NN	B-NP	B-DNA
care	care	NN	I-NP	I-DNA
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
home	home	NN	B-NP	O
health	health	NN	I-NP	O
aide	aide	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
RILEY	RILEY	NNP	B-NP	O
BENGTSON	BENGTSON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VF72	VF72	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MIQUEL	MIQUEL	NNP	B-NP	O
B.	B.	NNP	I-NP	O
FISCUS	FISCUS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HI2	HI2	NNP	I-NP	O
PJ475/0789	PJ475/0789	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
43911	43911	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

O3SBKK9W54	O3SBKK9W54	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/1/96	4/1/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/19/96	5/19/96	CD	B-NP	O

